Peripheral neuropathy increases the prevalence of diabetic foot ulcers following a decrease in foot sensation. Therefore, the treatment of this disorder is very important.

The current study aimed to investigate the efficacy of TECAR therapy on lower limb perfusion index (PI) and to evaluate the efficacy of TECAR therapy in improving the peripheral vascularity, reducing foot pain, and improving the tactile sensation of the soles in diabetic peripheral neuropathy (DPN) patients. twenty three diabetic neuropathy patients were included in the study and underwent 12 sessions of Capacitive TECAR therapy over one month. Pain, tactile sensation of the sole and PI were evaluated at the start and after each session till the end of the study.

Inclusion Criteria:

• Age 40-70 years
• Type II DM with DPN (grade I-II) in lower limbs
• Duration of DM>5 years
• Visual Analog Scale (VAS) ≥3 in the feet
• Sensory impairments in the lower extremities

Exclusion Criteria:

• Patient with previous stenting or surgical intervention of lower limb arterial system.
• Patients with previous history of DVT.
• Pregnancy
• Diabetic infectious wound
• Cardiac pacemaker presence
• Severe liver and kidney dysfunction or history of heart and lung disease.